NCT00943319
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The University of Chicago Chicago, Illinois, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,999 public trials
2,035 recruiting studies
Immunoproliferative Disorders trial results
NCT02381899
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Department of Hematology - Oncology, University Hospital Brno, Czechia
- 4th Department of Medicine - Hematology, University Hospital Hradec Králové, Czechia
- Department of Hematology, University Hospital Pilsen, Czechia
- Department of Medicine - Hematology, University Hospital Kralovske Vinohrady Prague, Czechia
- Conditions
- Graft vs Host Disease, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
- Locations
-
- Emory University Hospital Atlanta, Georgia, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Minnesota Minneapolis, Minnesota, United States
NCT02275403
- Conditions
- Blood Protein Disorders, Breast Cancer, Breast Diseases, +24 more
- Locations
-
- The Christie NHS Foundation Trust Manchester, United Kingdom
- The Royal Oldham Hospital Oldham, United Kingdom
Completed
Proton Therapy for Hodgkin Lymphoma
NCT00850200
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- University of Florida Proton Therapy Institute Jacksonville, Florida, United States
NCT03821727
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- GITMO Centers and GITMO CLINICAL OFFICE-AOU-IRCSS San Martino-Ge Genova, Italy
- University Hospital, Udine Udine, Italy
NCT02566265
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +25 more
- Locations
-
- Yale University New Haven, Connecticut, United States
Completed
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas
NCT01897012
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
CLL Empirical Antibiotic Regimen
NCT01279252
- Conditions
- Chronic Lymphocytic Leukaemia (CLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- King's College Hospital NHS Foundation Trust London, United Kingdom
NCT02844842
- Conditions
- Allergic Rhinitis, Asthma, Bronchial Diseases, +21 more
- Locations
-
- C.H.U A Coruña A Coruña, Spain
- Hopsital de Vinalopó Elche, Spain
- Clínica Dr. Arias Irigoyen Huelva, Spain
- Clínica Dra. Victoria Moreno Huelva, Spain